DOCSLIB.ORG

Congressional Record United States Th of America PROCEEDINGS and DEBATES of the 115 CONGRESS, FIRST SESSION

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Congressional Record United States Th of America PROCEEDINGS and DEBATES of the 115 CONGRESS, FIRST SESSION E PL UR UM IB N U U S Congressional Record United States th of America PROCEEDINGS AND DEBATES OF THE 115 CONGRESS, FIRST SESSION Vol. 163 WASHINGTON, TUESDAY, MARCH 7, 2017 No. 39 House of Representatives The House met at noon and was jority when that law went into effect, What this bill does is, again, it just called to order by the Speaker pro tem- there have been 60 votes to repeal the basically decapitates the Medicaid ex- pore (Mr. SIMPSON). Affordable Care Act; and up until this pansion. So about 11 million Americans f morning, the majority has always are going to have their healthcare cov- begged the question about: What is erage threatened. And those are not DESIGNATION OF SPEAKER PRO your replacement? Again, just last just, you know, people on entitlement TEMPORE week, we heard rumors that there was programs. We are talking about work- The SPEAKER pro tempore laid be- a replacement, that the Speaker actu- ing Americans. fore the House the following commu- ally had drafted a bill. I know a farmer in my district who nication from the Speaker: Well, with scenes that looked like it almost lost his foot from a chain saw WASHINGTON, DC, was out of ‘‘The Blair Witch Project,’’ accident, who thanked me the other March 7, 2017. we had Members of Congress going day that he had Medicaid to cover the I hereby appoint the Honorable MICHAEL K. around the Capitol opening doors with costs of his hospital coverage. SIMPSON to act as Speaker pro tempore on cameras doing live streams and live Again, the subsidies which allowed this day. coverage, again, to empty rooms and people to buy plans on the insurance PAUL D. RYAN, Speaker of the House of Representatives. denials that there actually was a bill marketplace, well, they basically, as I that anyone could actually take a look said, decapitate Medicaid. And they f at. also convert the subsidies from an in- MORNING-HOUR DEBATE Well, as I said, this morning, we now come-based system to an age-rated one, The SPEAKER pro tempore. Pursu- have been told that there actually is a which means that, basically, a well-to- ant to the order of the House of Janu- bill that has been filed, which tomor- do person gets the same tax credit that ary 3, 2017, the Chair will now recog- row will be marked up and voted out of a poor person or a single parent has. nize Members from lists submitted by committee with not one single public A conservative economist, Avik Roy, the majority and minority leaders for hearing and, incredibly, with no anal- just a few minutes ago, issued a state- morning-hour debate. ysis by the Congressional Budget Of- ment, saying: The Chair will alternate recognition fice, which any bill that has any im- Expanding subsidies for high earners while between the parties, with each party pact on budget, whether it is a tax bill cutting health coverage for the working poor limited to 1 hour and each Member or a spending bill, has, as a matter of sounds like a caricature of mustache-twirl- other than the majority and minority course, for decades, always been the ing, top-hatted Republican fat cats. leaders and the minority whip limited case. There is no measure which con- Again, you cannot imagine a more to 5 minutes, but in no event shall de- tains more significance in terms of a Robin Hood in reverse than a plan that bate continue beyond 1:50 p.m. Congressional Budget analysis than re- does what this tax credit change en- f forming the healthcare system of compasses. America, which constitutes about 15 to And, again, the list goes on and on in THE AMERICAN HEALTH CARE 20 percent of the American economy terms of some of the really just out- ACT and affects the lives of tens of millions rageous proposals that this new meas- The SPEAKER pro tempore. The of Americans. ure contains. Chair recognizes the gentleman from Well, from what we have seen so far, For seniors, again, the Affordable Connecticut (Mr. COURTNEY) for 5 min- it appears there is a good reason that Care Act contracted the age rating utes. the folks wanted to keep the bill a se- from 3 to 1 from what existed before; it Mr. COURTNEY. Mr. Speaker, 7 cret. Again, the basic fundamentals of was about 6 to 7 to 1. In other words, a years ago, in March of 2010, the Afford- the Affordable Care Act is built on two senior, an older person, could be able Care Act was signed into law after pillars. There was an expansion of Med- charged seven times the same rate as a a 2-year process of hundreds of com- icaid, and there were subsidies based on 20-year-old. Again, the Affordable Care mittee meetings, exhaustive markups— income for Americans to be able to buy Act reduced that span to 3 to 1. which I personally participated in— insurance through the marketplace. This bill expands the span again to 5 floor debate that went on for days, and, In the State of Connecticut, where I to 1, which the American ARP has al- again, back-and-forth between the come from, we have cut the uninsured ready issued a statement, saying: House and the Senate. rate down to 3.6 percent from approxi- It is nothing more than an age tax. It is Since that date, despite the, again, mately 9 percent when the bill was charging people based on their age, which is bitter criticism by the Republican ma- signed into law 7 years ago. nothing that any human being can control. b This symbol represents the time of day during the House proceedings, e.g., b 1407 is 2:07 p.m. Matter set in this typeface indicates words inserted or appended, rather than spoken, by a Member of the House on the floor. H1539 . VerDate Sep 11 2014 00:38 Mar 08, 2017 Jkt 069060 PO 00000 Frm 00001 Fmt 7634 Sfmt 0634 E:\CR\FM\A07MR7.000 H07MRPT1 SSpencer on DSK4SPTVN1PROD with HOUSE H1540 CONGRESSIONAL RECORD — HOUSE March 7, 2017 It also, again, rolls back tax in- mandate penalties and taxes on pre- ter and improved markets. The basic creases, slight tax increases, for high scription drugs, over-the-counter medi- problem the Republicans have—and income earners, as Mr. Roy’s comment cations, health insurance premiums, they know this very well—is that the indicates, and worsens the fiscal sol- and medical devices. It will expand health insurance industry is exempt vency of the Medicare trust fund, re- health savings accounts to empower in- from the antitrust laws of the United duces its solvency by 4 years. dividuals and families to spend their States of America, so they can, and Again, the Catholic Health Associa- healthcare dollars the way they want they do, get together and collude. They tion has come out today criticizing and need. It will provide tax credits to collude to drive up prices. They collude this proposal. Again, just an incredible those who don’t receive insurance to share markets: hey, if you are pull- array of stakeholder groups all across through work or a government pro- ing out of that State, I will pull out of the country are already speaking out. gram, helping all Americans access this State and cut those kind of deals. The fact that this measure is going high quality, affordable health care. They can’t be prosecuted. forward in committee tomorrow morn- At the same time, we on the Edu- We had a bipartisan vote on the floor ing, less than, really, 24 hours for the cation and the Workforce Committee of this House when we were originally American people to have even a are working to advance additional re- considering the House version of the glimpse in terms of what is being pro- forms that will help expand coverage, Affordable Care Act—infinitely supe- posed without an analysis in terms of a make health care more affordable, and rior to the thing passed by the Senate budget score, again, is just an abuse of promote a healthy workforce. which we got stuck with—and it was the legislative and democratic process. One legislative proposal will em- over 400 votes to take away their anti- Mr. Speaker, again, we have seen an power small businesses to band to- trust immunity. Is that in this bill? outpouring of Americans over the last gether to negotiate lower healthcare Heck, no. They are the second largest 2 months at townhall meetings—I have costs on behalf of their employees. An- PAC contributor to the Republican had four of them—people telling heart- other will protect the ability of em- Party, so I am afraid we are not going felt stories about how the ACA helped ployers to self-insure, providing great- to take away their antitrust immu- them. Yes, we can improve the law. er access to affordable, flexible nity—but we are going to have a really There are many ideas that we can work healthcare plans for their workers. The free, competitive, and transparent mar- together on. That is what we should be third will give employers the legal cer- ket. You will be able to go out and get focused on, not butchering the law, tainty they need to offer employee your policies, whatever the insurance which this proposal seeks to do. wellness plans, helping to promote a companies have decided as they f healthy workforce and, again, lower colluded behind closed doors.
Load more

Recommended publications
  • Rare Disease Congressional Caucus
    Join the Rare Disease Congressional Caucus The bipartisan and bicameral Rare Disease Congressional Caucus is led by Representatives G. K. Butterfield (D-NC) and Gus Bilirakis (R-FL), and Senators Roger Wicker (R-MS) and Amy Klobuchar (D-MN) to promote awareness of rare disease issues. Background: There are over 7,000 rare disorders that together affect more than 30 million Americans and their families. Rare or orphan diseases are defined as diseases affecting fewer than 200,000 people in the United States. Many rare diseases are considered ultra-rare; some affect fewer than 100 people. Rare diseases include rare cancers, tropical or neglected diseases, genetic diseases and many pediatric diseases including cancers. Many of these diseases are life-threatening and have no treatment options. The Orphan Drug Act was enacted in 1983 to incentivize pharmaceutical companies to develop therapies for diseases that have relatively small patient populations. Despite the success of the Orphan Drug Act, 93% of rare diseases still do not have a treatment approved by the Food and Drug Administration. The science exists for many of these diseases to be treated; however, treatments may never be developed because of roadblocks in the development process, such as a lack of investment and a challenging regulatory environment. Additionally, while relatively few treatments have been approved, patients struggle with health insurance reimbursement and other coverage barriers that prohibit access to potentially lifesaving treatments. Solution: The Rare Disease Congressional Caucus helps bring public and Congressional awareness to the unique needs of the rare disease community (including patients, physicians, scientists, and industry), and creates opportunities to address barriers to the development of and access to life-altering treatments.
    [Show full text]
  • Rare Disease Congressional Caucus
    Please Join the Rare Disease Congressional Caucus The bipartisan and bicameral Rare Disease Congressional Caucus is led by Representative Leonard Lance (R- NJ), Representative G.K. Butterfield (D-NC), Senator Orrin Hatch (R-UT), and Senator Amy Klobuchar (D- MN) to promote awareness of rare disease issues. Rare Disease Legislative Advocates (RDLA) helps coordinate the Rare Disease Congressional Caucus. RDLA works to empower the individual to become an advocate by providing informational meetings, legislative resources, advocacy tools, and special events that support organizations and advocates working to promote rare disease legislation. RDLA’s objective is to grow the patient advocacy community and work collectively to ensure that patients have a voice on Capitol Hill. Contact: Vignesh Ganapathy, Associate Director for Advocacy and Government Relations, EveryLife Foundation for Rare Diseases, [email protected], Rep. Lance’s office: [email protected], or Senator Hatch’s office: [email protected] Background: There are more than 7,000 rare disorders that together affect more than 30 million Americans and their families. One in 10 Americans has a rare disease. The Orphan Drug Act was enacted in 1983 to encourage pharmaceutical companies to develop drugs for diseases that have relatively small patient populations. Rare or orphan diseases are defined as diseases affecting fewer than 200,000 people in the U.S. More than 80% of rare diseases are considered ultra-rare, affecting fewer than 6,000 people, some diseases affect fewer than 100. Rare diseases include rare cancers, tropical or neglected diseases, genetic diseases and many pediatric diseases including cancers. Many of these diseases are life-threatening and have no treatment options.
    [Show full text]
  • Entire Issue (PDF)
    E PL UR UM IB N U U S Congressional Record United States th of America PROCEEDINGS AND DEBATES OF THE 114 CONGRESS, SECOND SESSION Vol. 162 WASHINGTON, THURSDAY, FEBRUARY 25, 2016 No. 30 House of Representatives The House met at 10 a.m. and was The benefits of CCS are bringing the bombers—which have not been used called to order by the Speaker pro tem- folks who do not traditionally work to- in 65 years, have been unable to help us pore (Mr. HARDY). gether to the same table for the better- with the military challenges that we f ment of our Nation’s energy security. face now in the Middle East and are Often people believe they are forced going to consume huge sums of money DESIGNATION OF SPEAKER PRO to choose between supporting economic in this hopelessly redundant program. TEMPORE development or environmental stew- It is dangerous because of the cuts in The SPEAKER pro tempore laid be- ardship. However, this bill is evidence the nuclear nonproliferation program fore the House the following commu- that that is a false choice. Above all, of over $100 million. I mean, these are nication from the Speaker: CCS serves as a testament to the entre- real threats to our security. preneurial spirit and gumption found WASHINGTON, DC, We are battling ISIS now. They have throughout this great country. February 25, 2016. already obtained some low-grade nu- I hereby appoint the Honorable CRESENT In Texas District 11, I have seen this clear material in a facility near Mosul. HARDY to act as Speaker pro tempore on this innovative spirit daily.
    [Show full text]
  • 114Th Congress Congressional Member Organizations (Cmos)
    114th Congress Congressional Member Organizations (CMOs) Updated: 12/1/16 All Members listed below are officers of their respective caucuses; each caucus maintains its own membership list. Each staff designee is listed directly below their employing Member. 1916 Easter Rising Centennial Caucus Chair/Co-Chair(s): Rep. Brendan Boyle Carly Frame, 202-225-6111, [email protected] Rep. Mick Mulvaney Natalee Binkholder, 202-225-5501, [email protected] Ad Hoc Congressional Committee for Irish Affairs Chair/Co-Chair(s): Rep. Joseph Crowley Jeremy Woodrum, 202-225-3965 Rep. Eliot L. Engel Jason Steinbaum, 202-225-2464 Rep. Peter King Kevin Fogarty, 202-225-7896 Rep. Christopher H. Smith Mark Milosch, 202-225-3765 Agriculture and Rural America Taskforce Chair/Co-Chair(s): Rep. Richard Hudson William Baldwin, 202-225-3715, [email protected] Rep. Daniel T. Kildee Jordan Dickinson, 202-225-3611, [email protected] American Sikh Congressional Caucus Chair/Co-Chair(s): Rep. Judy Chu Joleen Rivera, 202-225-5464, [email protected] Rep. John Garamendi Emily Burns, 202-225-1880, [email protected] Rep. Patrick Meehan Jim Gray, 202-225-2011, [email protected] Rep. David Valadao Kristina Dunklin, 202-225-4695, [email protected] 1 Americans Abroad Caucus Chair/Co-Chair(s): Rep. Carolyn B. Maloney Elizabeth Darnall, 202-225-7944, [email protected] Rep. Mick Mulvaney Natalee Binkholder, 202-225-5501, [email protected] Arthritis Caucus Chair/Co-Chair(s): Rep. Anna Eshoo Erin Katzelnick-Wise, 202-225-8104, [email protected] Rep.
    [Show full text]
  • Congressional Record United States Th of America PROCEEDINGS and DEBATES of the 115 CONGRESS, FIRST SESSION
    E PL UR UM IB N U U S Congressional Record United States th of America PROCEEDINGS AND DEBATES OF THE 115 CONGRESS, FIRST SESSION Vol. 163 WASHINGTON, WEDNESDAY, MARCH 1, 2017 No. 36 House of Representatives The House met at 10 a.m. and was also known as El Sexto, was arrested faces. Will they be brave enough to do called to order by the Speaker pro tem- for writing ‘‘he’s gone’’ on a wall after so, to march with these defenseless la- pore (Mr. ROTHFUS). Fidel Castro’s death. dies, or do they just want a junket to f Mr. Speaker, the Cuban people lack glamorize Cuba? the most basic of human rights, and Not to mention the many human DESIGNATION OF SPEAKER PRO they are punished for any sentiment rights abuses that go unreported, Mr. TEMPORE that is not in accordance with the Cas- Speaker. Instead, the Cuban people The SPEAKER pro tempore laid be- tro regime. The former administration risk their lives to record abuses, to re- fore the House the following commu- of this wonderful country failed the port them to outside organizations. nication from the Speaker: people of Cuba. The Ladies in White, Las Damas de WASHINGTON, DC, Since the change in the Cuba policy, Blanco, march every Sunday, peace- March 1, 2017. reports show that the humanitarian fully protesting the unjust and bar- I hereby appoint the Honorable KEITH J. crisis has only gotten worse on the is- baric imprisonment of dissidents. ROTHFUS to act as Speaker pro tempore on land. The 2017 Freedom in the World re- Look at these images, Mr.
    [Show full text]
  • 115Th Congress 19
    CALIFORNIA 115th Congress 19 CALIFORNIA (Population 2010, 37,253,956) SENATORS DIANNE FEINSTEIN, Democrat, of San Francisco, CA; born in San Francisco, June 22, 1933; education: B.A., Stanford University, 1955; professional: elected to San Francisco Board of Supervisors, 1970–78; president of Board of Supervisors, 1970–71, 1974–75, 1978; Mayor of San Francisco, 1978–88; candidate for governor of California, 1990; recipient: Distinguished Woman Award, San Francisco Examiner; Achievement Award, Business and Professional Women’s Club, 1970; Golden Gate University, California, LL.D. (hon.), 1979; SCOPUS Award for Outstanding Public Service, American Friends of the Hebrew University of Jerusalem; Uni- versity of Santa Clara, D.P.S. (hon.); University of Manila, D.P.A. (hon.), 1981; Antioch Uni- versity, LL.D. (hon.), 1983; Los Angeles Anti-Defamation League of B’nai B’rith’s Distin- guished Service Award, 1984; French Legion d’Honneur from President Mitterand, 1984; Mills College, LL.D. (hon.), 1985; U.S. Army Commander’s Award for Public Service, 1986; Broth- erhood / Sisterhood Award, National Conference of Christians and Jews, 1986; Paulist Fathers Award, 1987; Episcopal Church Award for Service, 1987; U.S. Navy Distinguished Civilian Award, 1987; Silver Spur Award for Outstanding Public Service, San Francisco Planning and Urban Renewal Association, 1987; All Pro Management Team Award for No. 1 Mayor, City and State Magazine, 1987; Community Service Award Honoree for Public Service, 1987; Amer- ican Jewish Congress, 1987; President’s Award, St. Ignatius High School, San Francisco, 1988; Coro Investment in Leadership Award, 1988; President’s Medal, University of California at San Francisco, 1988; University of San Francisco, D.H.L.
    [Show full text]
  • Major News National MPS Awareness Day Power in Numbers Rare
    SUMMER 2013 courage Volume 37 | No. 2 03 05 28 35 43 Major News National Power in Rare Disease Upcoming Synageva, MPS Numbers Impact Events Ultragenyx Awareness Collaboration Report 2013 family and Lysogene Day between Mt. Sinai Survey uncovers conference to be all announce Families nationwide and Icahn School impact of rare held Oct. 24–26 in treatment progress find unique ways of Medicine offers diseases on San Antonio, TX. to honor those hope with new patient & medical Register online affected treatment communities now! 0081 courage v4_web.indd 1 6/12/13 5:28 PM The National MPS Society’s office (ground floor on left). Do you have a personal story or an article idea for a future issue of Courage? Please write to us and remember to send photos! ISSUE To submit information to Courage, please send text (preferably via e-mail) SPRING to the address below. Photos should be labeled whenever possible. Please SUBMISSION CUTOFF DATE note cutoff dates. Any information received after these dates will be January 1 included in the subsequent issue. ISSUE SUMMER The articles in this newsletter are for informational purposes only, and do SUBMISSION CUTOFF DATE not necessarily reflect the opinions of the National MPS Society and its April 1 board of directors. We do not endorse any of the medications, treatments or products reported in this newsletter, and strongly advise that you check ISSUE FALL any drugs or treatments mentioned with your physician. SUBMISSION CUTOFF DATE Courage reserves the right to edit content as necessary. July 1 ISSUE WINTER
    [Show full text]
  • Legislative Report
    March 12, 2014 Legislative Update for the Clinical Trials and Translational Research Advisory Committee Activities of the 113th Congress- Second Session Susan Erickson, Director, Office of Government and Congressional Relations National Cancer Institute Building 31-10A48 [email protected] 301-496-5217 Visit the Office of Government and Congressional Affairs website at: http://legislative.cancer.gov I. Appropriations On January 17th, the President signed Consolidated Appropriations Act of 2014 into law following Congressional passage of the omnibus funding bill with a House vote of 359-67 on 1/15/14, and a Senate vote of 72-26 on 1/16/14. Despite efforts to move the bill before the continuing resolution (CR) expired on January 15th, Congress was unable to do so and therefore needed to pass an emergency three-day Continuing Resolution (CR) to continue funding the government through January 18th. This “omnibus” appropriations act contains funding for all 12 Congressional Appropriation bills, including Labor- HHS-Education. It provides a $1 billion increase for NIH over the post-sequester funding level of FY2013 ($29.9 billion for FY2014 for NIH, including $4.92 billion for NCI). While this is an increase over the FY2013 funding level, the bill funds NIH and NCI at a level lower than FY2012, as well as lower than FY2011 and FY2010 levels. The funding levels provided by the omnibus bill are based on spending levels established by the Bipartisan Budget Act, an agreement reached between House Budget Chair Paul Ryan and Senate Budget Chair Patty Murray (House amendment to H.J.Res. 59/P.L.
    [Show full text]
  • View the Rare Disease Week on Capitol Hill 2019 Program
    Presented by FEBRUARY 24 – 28, 2019 Washington, DC #RareDC2019 @RareAdvocates POWERED BY THE EVERYLIFE FOUNDATION Thank You to Our Generous 2019 Rare Disease Week on Capitol Hill Sponsors PRESIDENTIAL LEADERSHIP RANKING CHAMPION CO-SPONSORS GRASSROOTS THIS HANDBOOK IS GENEROUSLY UNDERWRITTEN BY: Table of Contents Introduction Welcome 1 Schedule of Events 2-3 Sunday Documentary Screening 4 Monday Legislative Conference Agenda 5-9 Legislative Conference Guest Speakers 10-22 Tuesday Lobby Day Breakfast 23 Lobby Day Issue Information 24-26 Rare Disease Congressional Caucus 27 Congressional Meeting Tips 28 Legislative Process 29 Social Media Advocacy Tips 30 Young Adult Meetup 31 Wednesday Rare Disease Congressional Caucus Briefing 33 Rare Artist Reception 34 Thursday Rare Disease Day at NIH 35 About Rare Disease Legislative Advocates 36 Rare Hub 37 Newborn Screening 37 Rare on the Road 38 Notes Glossary 39-40 Share Your Rare Story 43 Notes 44 Maps Share Your Rare Experience Metro 45 US Capitol 46 #RareDC2019 @RareAdvocates #RareDC2019 The EveryLife Team Julia Jenkins Executive Director [email protected] Carol Kennedy Chief Development Officer [email protected] Christina Hartman Senior Director of Policy and Advocacy [email protected] Dear Rare Disease Advocate, Britta Vander Linden Thank you for joining us for Rare Disease Week Senior Director of Communications on Capitol Hill. This event is a success because and Marketing of your participation and determination to be [email protected] an effective advocate for yourself or loved ones. We are honored that you have chosen to Ted Brasfield advocate with us in DC. Director of Development [email protected] As you know, Washington is often gridlocked with partisan bickering.
    [Show full text]
  • 114Th Congress Congressional Member Organizations (Cmos)
    114th Congress Congressional Member Organizations (CMOs) Updated: 2/23/2015 All Members listed below are officers of their respective caucuses; each caucus maintains its own membership list. Americans Abroad Caucus Date Approved: 2/18/2015 Chairs & Co-Chairs: Rep. Carolyn Maloney; Rep. Mick Mulvaney; Staff Contact Name and Information: Elizabeth Darnall (Maloney) 202.225.7944, [email protected] Natalee Binkholder (Mulvaney) 202.225.5501, [email protected] Americans Affordable Medicines Caucus Date Approved: 2/18/2015 Chairs & Co-Chairs: Rep. Peter Welch; Rep. Keith Rothfus Staff Contact Name and Information: Isaac Loeb (Welch) 202.225.4115, [email protected] Danielle Janowski (Rothfus) 202.225.2065, [email protected] Congressional Azerbaijan Caucus Date Approved: 2/4/2015 Chairs & Co-Chairs: Rep. Bill Shuster; Rep. Steve Cohen Staff Contact Name and Information: Sean Joyce (Shuster) 202.225.2431, [email protected] Marilyn Dillihay (Cohen) 202.225.3265, [email protected] Congressional Black Caucus Date Approved: 1/22/2015 Chairs & Co-Chairs: Rep. G.K. Butterfield Staff Contact Name and Information: Abdul Henderson (Butterfield) 202.226.9776, [email protected] Congressional Boating Caucus Date Approved: 2/3/2015 Chairs & Co-Chairs: Rep. Candice Miller; Rep. Patrick Murphy Staff Contact Name and Information: Dena Kozanas (Miller) 202.225.2106, [email protected] Morgan Cashwell (Murphy) 202.225.3026, [email protected] Congressional Bourbon Caucus Date Approved: 2/23/2015 Chairs & Co-Chairs: Rep. Brett Guthrie; Rep. John Yarmuth Staff Contact Name and Information: Megan Jackson (Guthrie) 202.225.3501, [email protected] Zack Marshall (Yarmuth) 202.225.5401, [email protected] Congressional Caucus on CPAs and Accountants Date Approved: 2/18/2015 Chairs & Co-Chairs: Rep.
    [Show full text]
  • Join the Rare Disease Congressional Caucus
    Join the Rare Disease Congressional Caucus The bipartisan and bicameral Rare Disease Congressional Caucus is led by Representatives G. K. Butterfield (D-NC) and Gus Bilirakis (R-FL), and Senators Roger Wicker (R-MS) and Amy Klobuchar (D-MN) to promote awareness of rare disease issues. Background: There are over 7,000 rare disorders that together affect more than 30 million Americans and their families. Rare or orphan diseases are defined as diseases affecting fewer than 200,000 people in the United States. Many rare diseases are considered ultra-rare; some affect fewer than 100 people. Rare diseases include genetic diseases, rare cancers, tropical or neglected diseases, and many pediatric diseases. Many of these diseases are life-threatening and have no treatment options. The Orphan Drug Act was enacted in 1983 to incentivize pharmaceutical companies to develop therapies for diseases that have relatively small patient populations. Despite the success of the Orphan Drug Act, 93-95% of rare diseases still do not have a treatment approved by the Food and Drug Administration. The science exists for many of these diseases to be treated; however, treatments may never be developed because of roadblocks in the development process, such as a lack of investment and a challenging regulatory environment. Additionally, while relatively few treatments have been approved, patients struggle with health insurance reimbursement and other coverage barriers that prohibit access to potentially lifesaving treatments. Solution: The Rare Disease Congressional Caucus helps bring public and Congressional awareness to the unique needs of the rare disease community (including patients, physicians, scientists, and industry), and creates opportunities to address barriers to the development of and access to life-altering treatments.
    [Show full text]
  • 115Th Congress 19
    CALIFORNIA 115th Congress 19 CALIFORNIA (Population 2010, 37,253,956) SENATORS DIANNE FEINSTEIN, Democrat, of San Francisco, CA; born in San Francisco, June 22, 1933; education: B.A., Stanford University, 1955; professional: elected to San Francisco Board of Supervisors, 1970–78; president of Board of Supervisors, 1970–71, 1974–75, 1978; Mayor of San Francisco, 1978–88; candidate for governor of California, 1990; recipient: Distinguished Woman Award, San Francisco Examiner; Achievement Award, Business and Professional Women’s Club, 1970; Golden Gate University, California, LL.D. (hon.), 1979; SCOPUS Award for Outstanding Public Service, American Friends of the Hebrew University of Jerusalem; Uni- versity of Santa Clara, D.P.S. (hon.); University of Manila, D.P.A. (hon.), 1981; Antioch Uni- versity, LL.D. (hon.), 1983; Los Angeles Anti-Defamation League of B’nai B’rith’s Distin- guished Service Award, 1984; French Legion d’Honneur from President Mitterand, 1984; Mills College, LL.D. (hon.), 1985; U.S. Army Commander’s Award for Public Service, 1986; Broth- erhood / Sisterhood Award, National Conference of Christians and Jews, 1986; Paulist Fathers Award, 1987; Episcopal Church Award for Service, 1987; U.S. Navy Distinguished Civilian Award, 1987; Silver Spur Award for Outstanding Public Service, San Francisco Planning and Urban Renewal Association, 1987; All Pro Management Team Award for No. 1 Mayor, City and State Magazine, 1987; Community Service Award Honoree for Public Service, 1987; Amer- ican Jewish Congress, 1987; President’s Award, St. Ignatius High School, San Francisco, 1988; Coro Investment in Leadership Award, 1988; President’s Medal, University of California at San Francisco, 1988; University of San Francisco, D.H.L.
    [Show full text]